Immunological analysis
Investigation . | Patient 1 . | Normal range . |
---|---|---|
Total immunoglobulins | ||
IgG (g/L) | 3.06 | 3.1-13.8 |
IgA (g/L) | 0.50 | 0.3-1.2 |
IgM (g/L) | 1.47 | 0.5-2.2 |
Specific antibodies* | ||
Tetanus (IU/mL) | < 0.012 | 0.1-2 |
Hemophilus influenzaeB (μm/mL) | < 0.15 | > 0.15 (minimum protective level) |
Lymphocytes | ||
Total lymphocytes (cells/mm3) | 1790 | 3100-8700 |
CD3 | 268 | 1800-5900 |
CD3+CD4+ | 72 | 1300-4100 |
CD3+CD8+ | 215 | 500-1600 |
CD19 | 1396 | 700-2400 |
CD16+CD56+ | < 9 | 200-900 |
PHA response | ||
PHA 0 μg/mL | 609 dpm | |
PHA 2.0 μg/mL | 2370 dpm | |
Stimulation index | 3.8 | > 100 |
Investigation . | Patient 1 . | Normal range . |
---|---|---|
Total immunoglobulins | ||
IgG (g/L) | 3.06 | 3.1-13.8 |
IgA (g/L) | 0.50 | 0.3-1.2 |
IgM (g/L) | 1.47 | 0.5-2.2 |
Specific antibodies* | ||
Tetanus (IU/mL) | < 0.012 | 0.1-2 |
Hemophilus influenzaeB (μm/mL) | < 0.15 | > 0.15 (minimum protective level) |
Lymphocytes | ||
Total lymphocytes (cells/mm3) | 1790 | 3100-8700 |
CD3 | 268 | 1800-5900 |
CD3+CD4+ | 72 | 1300-4100 |
CD3+CD8+ | 215 | 500-1600 |
CD19 | 1396 | 700-2400 |
CD16+CD56+ | < 9 | 200-900 |
PHA response | ||
PHA 0 μg/mL | 609 dpm | |
PHA 2.0 μg/mL | 2370 dpm | |
Stimulation index | 3.8 | > 100 |
PHA indicates phytohemagglutinin; dpm, disintegrations per minute.
After full immunization.